# The Effect of Dapagliflozin on Patients With Cardiomyopathy

> **NCT07076615** · PHASE4 · RECRUITING · sponsor: **May Mohamed Abdalla** · enrollment: 100 (estimated)

## Conditions studied

- Acute Decompensated Heart Failure (ADHF)

## Interventions

- **DRUG:** Dapagliflozin (DAPA)
- **DRUG:** Diuretic

## Key facts

- **NCT ID:** NCT07076615
- **Lead sponsor:** May Mohamed Abdalla
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2025-08
- **Primary completion:** 2026-05
- **Final completion:** 2026-05
- **Target enrollment:** 100 (ESTIMATED)
- **Last updated:** 2025-08-22

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07076615

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07076615, "The Effect of Dapagliflozin on Patients With Cardiomyopathy". Retrieved via AI Analytics 2026-07-20 from https://api.ai-analytics.org/clinical/NCT07076615. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*